The molecular mechanisms of cellular tolerance to delta-opioid agonists. A minireview

Eva V Varga1

  • 1Department of Pharmacology, Sarver Heart Center, The University of Arizona, Tucson, Arizona, USA. evarga@email.arizona.edu

Acta Biologica Hungarica
|October 11, 2003
PubMed

Insights

Chronic delta-opioid agonist use causes tolerance through cellular adaptations. Distinct agonists trigger different receptor down-regulation pathways, impacting cellular signaling and adenylyl cyclase activity.

Area of Science:

  • Pharmacology
  • Molecular Biology
  • Neuroscience

Background:

  • Chronic administration of delta-opioid agonists leads to tolerance, a complex adaptive response involving cellular and neural system changes.
  • Cellular tolerance encompasses receptor desensitization (altered function, concentration, localization) and functional desensitization of intracellular effectors.

Purpose of the Study:

  • To investigate the molecular mechanisms underlying cellular tolerance to delta-opioid agonists.
  • To elucidate the differential effects of structurally distinct agonists on delta-opioid receptor (hDOR) regulation and downstream signaling.

Main Methods:

  • Utilized a recombinant Chinese hamster ovary (hDOR/CHO) cell line expressing human delta-opioid receptors.
  • Analyzed receptor down-regulation mechanisms in response to different delta-opioid agonists (DPDPE, SNC 80).
  • Assessed functional desensitization of forskolin-stimulated cAMP formation and adenylyl cyclase (AC) VI phosphorylation.

Main Results:

  • Structurally distinct delta-opioid agonists mediate hDOR down-regulation via different mechanisms; C-terminal truncation affected DPDPE but not SNC 80.
  • Down-regulation of wild-type and truncated hDORs exhibited differential inhibitor sensitivity.
  • Chronic SNC 80 treatment induced functional desensitization, cAMP overshoot, and concurrent phosphorylation of AC VI, which was dose-dependent and naltrindole-sensitive.

Conclusions:

  • Delta-opioid receptor down-regulation pathways are agonist-specific.
  • Phosphorylation of adenylyl cyclase VI is implicated in delta-opioid agonist-induced adenylyl cyclase superactivation.
  • These findings provide molecular insights into the cellular adaptations driving delta-opioid tolerance.

Related Concept Videos

Analgesia and Pain Management01:25

Analgesia and Pain Management

Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
Opioid Receptors: Overview01:22

Opioid Receptors: Overview

Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2, D-Pen5]-enkephalin or DPDPE for...
Opioid Analgesics: Morphine and Other Natural Cogeners01:20

Opioid Analgesics: Morphine and Other Natural Cogeners

Opioids are a class of drugs that mimic endogenous opioid peptides and act on opioid receptors, and help in pain relief. These compounds are classified as natural, synthetic, or semi-synthetic. Natural opioids, like morphine, codeine, and thebaine, are derived from the opium poppy plant (Papaver somniferum or Papaver album) and are termed opiates. Synthetic opioids are artificial, while semi-synthetic opioids combine natural and synthetic compounds. Morphine, a prototypical opioid, possesses a...
Opioid Analgesics: Synthetic and Semisynthetic Opioids01:15

Opioid Analgesics: Synthetic and Semisynthetic Opioids

Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
Drugs Affecting GI Tract Motility: Opioids as Antidiarrheal Agents01:17

Drugs Affecting GI Tract Motility: Opioids as Antidiarrheal Agents

Diarrhea, a condition marked by frequent loose or watery bowel movements, can be triggered by multiple factors such as viral or bacterial infections, food intolerances, anxiety, medications, and digestive disorders. Symptoms may include abdominal pain, bloating, nausea, and cramping. Severe or prolonged diarrhea can lead to complications like electrolyte imbalances, malnutrition, and dehydration if left untreated.
Opioids, widely used antidiarrheal agents, mitigate diarrhea by slowing down...
Desensitization and Tachyphylaxis01:20

Desensitization and Tachyphylaxis

Tachyphylaxis is described as a rapid decrease in response to a drug after repeated or continuous administration of the same drug dose. It is a phenomenon where the body becomes less responsive to a particular substance or intervention over time, requiring higher doses or stronger interventions to achieve the same effect. It results from adaptive changes in the body's receptors, signaling pathways, or physiological processes that occur in response to prolonged exposure to a stimulus.
Several...